TABLE 2.
Estimate for hospital length of stay according to 25-hydroxyvitamin D (ng/mL) categories in patients with moderate to severe COVID-191
| Hospital length of stay | n/Total n2 | Estimated days, median (95% CI) | P3 |
|---|---|---|---|
| Model 1 | 0.120 | ||
| <10 ng/mL | 15/16 | 9.0 (6.4, 11.6) | |
| 10 to <20 ng/mL | 96/97 | 7.0 (6.4, 7.6) | |
| 20 to <30 ng/mL | 67/71 | 7.0 (6.3, 7.7) | |
| ≥ 30 | 28/30 | 7.0 (6.3, 7.7) | |
| Model 2 | 0.057 | ||
| <10 ng/mL | 15/16 | 9.0 (6.4, 11.6) | |
| ≥10 ng/mL | 191/198 | 7.0 (6.6, 7.4) |
1
COVID-19, coronavirus disease 2019.
2
Number of surviving patients (censored events, death, n = 8)/total patients with available information (excluding dropouts, n = 6).
3
Log-rank test for categorical variables.